- Molecules
- 11
MedsAcross lists 11 molecules linked to Myelofibrosis, each with brands, manufacturers and supply from India for licensed hospitals and physicians.
Medicines used
Molecules linked to this condition in public data. The prescriber decides which treatment is right.
- LenalidomideOrphanThalidomide Analog12 presentations6 brandsL04AX04
- DeferasiroxOrphanIron Chelator24 presentations7 brandsV03AC03
- PomalidomideOrphanThalidomide Analog8 presentations7 brandsL04AX06
- AzacitidineOrphanNucleoside Metabolic Inhibitor7 presentations8 brandsL01BC07
- RuxolitinibOrphanJanus Kinase Inhibitor11 presentations6 brandsD11AH09
- BusulfanOrphanAlkylating Drug2 presentations2 brandsL01AB01
- ThalidomideOrphanDecreased Immunologically Active Molecule Activity4 presentations3 brandsL04AX02
- MomelotinibOrphanKinase Inhibitor3 presentations2 brands
- Peginterferon alfa-2aBiologicInterferon alpha2 presentations1 brandL03AB11
- FedratinibOrphan1 presentation2 brandsL01EJ02
- PacritinibOrphanKinase Inhibitor1 presentation1 brand
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Need a medicine for Myelofibrosis?
Physicians and hospitals can request named-patient supply. We guide you through the documents your country requires.